(Q39814133)

14 September 2017

title

Combination of hyperthermia and bortezomib results in additive killing in mantle cell lymphoma cells (English)

1 reference

14 September 2017

1 reference

Valeria Milani

1

1 reference

14 September 2017

Monika Lorenz

2

1 reference

14 September 2017

Marc Weinkauf

3

1 reference

14 September 2017

Malte Rieken

4

1 reference

14 September 2017

Alessandro Pastore

5

1 reference

14 September 2017

Martin Dreyling

6

1 reference

14 September 2017

Rolf Issels

7

1 reference

14 September 2017

publication date

1 June 2009

1 reference

International Journal of Hyperthermia

14 September 2017

published in

1 reference

14 September 2017

volume

25

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

262-272

1 reference

14 September 2017

cites work

Proteasome plasticity.

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

A phase 2 study of bortezomib in relapsed, refractory myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Current management of mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

21 January 2018

Hyperthermia in oncology

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Cell biological effects of hyperthermia alone or combined with radiation or drugs: a short introduction to newcomers in the field.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Reduction of cellular cisplatin resistance by hyperthermia--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Molecular chaperones and protein quality control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Molecular chaperones and the stress of oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Proteomic analysis of mantle-cell lymphoma by protein microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Expression of heat-shock protein-90 in non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Sequence-dependent synergy of the proteasome inhibitor bortezomib and cytarabine in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Melanoma-associated antigen tyrosinase but not Melan-A/MART-1 expression and presentation dissociate during the heat shock response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Heat shock protein 90 as a molecular target for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Heat-shock protein expression in cisplatin-sensitive and -resistant human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Protein-damaging stresses activate c-Jun N-terminal kinase via inhibition of its dephosphorylation: a novel pathway controlled by HSP72.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

The effect of heat shock on 20S/26S proteasomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Heat shock and the activation of AP-1 and inhibition of NF-kappa B DNA-binding activity: possible role of intracellular redox status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Hyperthermia-induced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Proteasome inhibition potentiates the cytotoxic effects of hyperthermia in HT-29 colon cancer cells through inhibition of heat shock protein 27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Cellular and biochemical events in mammalian cells during and after recovery from physiological stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib*

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730902835664

10.1080/02656730902835664

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference